TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Vifor Pharma Nordiska AB
Closing information (x1000 DKK)
Closing information | 2024/06 | 2023/06 | 2021/12 |
Turnover |
216,790
|
274,487
|
177,340 |
Financial expenses |
611
|
891
|
537 |
Earnings before taxes |
17,213
|
4,956
|
5,209 |
EBITDA |
17,215
|
6,011
|
5,885 |
Total assets |
248,208
|
157,132
|
192,363 |
Current assets |
248,149
|
156,960
|
191,957 |
Current liabilities |
128,586
|
55,028
|
78,953 |
Equity capital |
44,125
|
29,477
|
29,789 |
- share capital |
131
|
126
|
145 |
Employees (average) |
38
|
46
|
40 |
Financial ratios
Fiscal year | 2024/06 | 2023/06 | 2021/12 |
Solvency |
17.8%
|
18.8%
|
15.5% |
Turnover per employee |
5,705
|
5,967
|
4,434 |
Profit as a percentage of turnover |
7.9%
|
1.8%
|
2.9% |
Return on assets (ROA) |
7.2%
|
3.7%
|
3.0% |
Current ratio |
193.0%
|
285.2%
|
243.1% |
Return on equity (ROE) |
39.0%
|
16.8%
|
17.5% |
Change turnover |
-68,546
|
120,461
|
13,120 |
Change turnover % |
-24%
|
78%
|
8% |
Chg. No. of employees |
-8
|
6
|
2 |
Chg. No. of employees % |
-17%
|
15%
|
5% |
Total value of public sale
Fiscal year | 2024/06 | 2023/06 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.